The growing inclination of patients towards non-invasive and minimally invasive surgical treatments; increasing geriatric, diabetic, and obese population; and procedural and cost benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market. However, legal issues against market players and side effects associated with BMP-based orthopedic treatment are the key challenges faced by the majority of the bone growth stimulators manufacturers.